NCT05685602 2026-03-19CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic CancerNational Cancer Institute (NCI)Phase 1 Recruiting43 enrolled
NCT02810418 2022-03-15Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed40 enrolled 37 charts